Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Infliximab versus Cyclophosphamide for Severe Behçet's Syndrome.
Saadoun D, Maalouf G, Vieira M, Trad S, Lazaro E, Sacre K, Plessier A, Sené T, Koné-Paut I, Noel N, Mekinian A, Lambert M, Ribeiro E, Mirault T, Mele N, Dellal A, Fain O, Melki I, Chiche L, Gaudric J, Redheuil A, Maillart E, Ghembaza A, Desbois AC, Mirouse A, Domont F, Leroux G, Ferfar Y, Rigolet A, Viallard JF, Vautier M, Resche-Rigon M, Cacoub P. Saadoun D, et al. Among authors: plessier a. NEJM Evid. 2024 Nov;3(11):EVIDoa2300354. doi: 10.1056/EVIDoa2300354. Epub 2024 Oct 22. NEJM Evid. 2024. PMID: 39437137 Clinical Trial.
Alemtuzumab-based conditioning regimen before hematopoietic stem cell transplantation in patients with short telomere syndromes: a retrospective study of the SFGM-TC.
Hussein-Agha R, Kannengiesser C, Lainey E, Marcais A, Srour M, Sterin A, Buchbinder N, Borie R, Plessier A, Socié G, Peffault de Latour R, Sicre de Fontbrune F. Hussein-Agha R, et al. Among authors: plessier a. Bone Marrow Transplant. 2024 Oct;59(10):1428-1432. doi: 10.1038/s41409-024-02381-5. Epub 2024 Jul 30. Bone Marrow Transplant. 2024. PMID: 39080469
Haematological features of telomere biology disorders diagnosed in adulthood: A French nationwide study of 127 patients.
Maillet F, Galimard JE, Borie R, Lainey E, Larcher L, Passet M, Plessier A, Leblanc T, Terriou L, Lebon D, Alcazer V, Cathebras P, Loschi M, Wadih AC, Marcais A, Marceau-Renaut A, Couque N, Lioure B, Soulier J, Ba I, Socié G, Peffault de Latour R, Kannengiesser C, Sicre de Fontbrune F. Maillet F, et al. Among authors: plessier a. Br J Haematol. 2024 Nov;205(5):1835-1847. doi: 10.1111/bjh.19767. Epub 2024 Sep 15. Br J Haematol. 2024. PMID: 39279213
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study.
Perez-Campuzano V, Rautou PE, Marjot T, Praktiknjo M, Alvarado-Tapias E, Turco L, Ibáñez-Samaniego L, González-Alayón C, Puente Á, Llop E, Simón-Talero M, Álvarez-Navascués C, Reiberger T, Verhelst X, Tellez L, Bergmann JB, Orts L, Grassi G, Baiges A, Audrey P, Trebicka J, Villanueva C, Morelli MC, Murray S, Meacham G, Luetgehetmann M, Schulze Zur Wiesch J, García-Pagán JC, Barnes E, Plessier A, Hernández-Gea V; ERN RARE-LIVER; a study of VALDIG, an EASL consortium and REHEVASC. Perez-Campuzano V, et al. Among authors: plessier a. JHEP Rep. 2024 Aug 22;6(12):101191. doi: 10.1016/j.jhepr.2024.101191. eCollection 2024 Dec. JHEP Rep. 2024. PMID: 39583091 Free PMC article.
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies.
Elkrief L, Hernandez-Gea V, Senzolo M, Albillos A, Baiges A, Berzigotti A, Bureau C, Murad SD, De Gottardi A, Durand F, Garcia-Pagan JC, Lisman T, Mandorfer M, McLin V, Moga L, Nery F, Northup P, Nuzzo A, Paradis V, Patch D, Payancé A, Plaforet V, Plessier A, Poisson J, Roberts L, Salem R, Sarin S, Shukla A, Toso C, Tripathi D, Valla D, Ronot M, Rautou PE; ERN RARE-LIVER and VALDIG, an EASL consortium. Elkrief L, et al. Among authors: plessier a. Lancet Gastroenterol Hepatol. 2024 Sep;9(9):859-883. doi: 10.1016/S2468-1253(24)00155-9. Epub 2024 Jul 9. Lancet Gastroenterol Hepatol. 2024. PMID: 38996577 Review.
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder.
Moga L, Paradis V, Ferreira-Silva J, Gudavalli K, Indulti F, Dajti E, Nicoara-Farcau O, Tosetti G, Antonenko A, Fodor A, Vidal-González J, Turco L, Capinha F, Elkrief L, Monllor-Nunell T, Goria O, Balcar L, Lannes A, Mallet V, Poujol-Robert A, Thabut D, Houssel-Debry P, Wong YJ, Ronot M, Vilgrain V, Rampally SP, Payancé A, Castera L, Reiberger T, Ferrusquía-Acosta J, Noronha Ferreira C, Vitale G, Simon-Talero M, Procopet B, Berzigotti A, Caccia R, Turon F, Schepis F, Ravaioli F, Colecchia A, Valsan A, Macedo G, Plessier A, Rautou PE; ERN RARE-LIVER; a study of VALDIG, an EASL consortium. Moga L, et al. Among authors: plessier a. Hepatology. 2024 Jul 2. doi: 10.1097/HEP.0000000000001004. Online ahead of print. Hepatology. 2024. PMID: 38954825
French guidelines on TIPS: Indications and modalities.
Larrue H, Allaire M, Weil-Verhoeven D, Barge S, Thabut D, Payance A, Moga L, Jézéquel C, Artru F, Archambeaud I, Elkrief L, Oberti F, Roux C, Laleman W, Rudler M, Dharancy S, Laborde N, Minello A, Mouillot T, Desjonquères E, Wandji LCN, Bourlière M, Ganne-Carrié N, Bureau C; Groupe collaboratif AFEF. Larrue H, et al. Liver Int. 2024 Sep;44(9):2125-2143. doi: 10.1111/liv.15976. Epub 2024 May 17. Liver Int. 2024. PMID: 38758295
Abdominal surgery in patients with chronic noncirrhotic extrahepatic portal vein obstruction: A multicenter retrospective study.
Elkrief L, Denecheau-Girard C, Magaz M, Praktiknjo M, Colucci N, Ollivier-Hourmand I, Dumortier J, Simon Talero M, Tellez L, Artru F, Meszaros M, Verhelst X, Tabchouri N, Beires F, Andaluz I, Leo M, Diekhöner M, Dokmak S, Fundora Y, Vidal-Gonzalez J, Toso C, Plessier A, Carlos Garcia Pagan J, Rautou PE; ERN RARE-LIVER; a study of VALDIG, an EASL consortium. Elkrief L, et al. Among authors: plessier a. Hepatology. 2025 Jan 1;81(1):152-167. doi: 10.1097/HEP.0000000000000901. Epub 2024 Apr 29. Hepatology. 2025. PMID: 38683626
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors.
Ollivier-Hourmand I, Lebedel L, Alabau BB, Goria O, Bureau C, Dumortier J, Heurgué A, Silvain C, De-Ledinghen V, Rautou PE, Payancé A, Ballester TG, Alvarado-Tapias E, Hernández-Gea V, Valla D, Zekrini K, Nga Nguyen TT, Dao T, Garcia Pagan JC, Morello R, Plessier A. Ollivier-Hourmand I, et al. Among authors: plessier a. J Hepatol. 2024 Sep;81(3):451-460. doi: 10.1016/j.jhep.2024.04.016. Epub 2024 Apr 26. J Hepatol. 2024. PMID: 38679069
Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination: A Vascular Liver Disease Group (VALDIG) initiative.
Maan R, Lauw MN, China L, Patch D, Baiges A, Garcia-Pagan JC, Hernández-Gea V, Hilleret MN, Tjwa ET, Kounis I, Bureau C, Giguet B, Heurgué A, Ollivier-Hourmand I, Causse X, Nery F, Eshraghian A, Plessier A, Darwish Murad S. Maan R, et al. Among authors: plessier a. Hepatology. 2024 Nov 1;80(5):1147-1157. doi: 10.1097/HEP.0000000000000787. Epub 2024 Feb 15. Hepatology. 2024. PMID: 38358465
140 results